Clinical trialNCT03020719CompletedPhase 2Interventional

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

SponsorUniversity of MinnesotaEnrollment60Cystic Fibrosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Molly Bozic, MD
Indiana University School of Medicine Riley Hospital
Principal Investigator
clinicaltrials.gov ↗
Sarah J Schwarzenberg, MD
University of Minnesota
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Childrens Hospital Colorado
Aurora, Colorado, United States
Connecticut Childrens Medical Center
Hartford, Connecticut, United States
Nemours Childrens Clinic
Jacksonville, Florida, United States
Nemours Children'S Clinic
Pensacola, Florida, United States
Emory University Hospital
Atlanta, Georgia, United States
Riley Children'S Hospital
Indianapolis, Indiana, United States
Childrens Hospital of Michigan
Detroit, Michigan, United States
Helen Devos Women and Childrens Center
Grand Rapids, Michigan, United States
University of Minnesota Medical Center
Minneapolis, Minnesota, United States
the Childrens Mercy Hospital
Kansas City, Missouri, United States
Women and Childrens Hospital of Buffalo
Buffalo, New York, United States
Childrens Hospital of New York/columbia University Medical Center
New York, New York, United States
Oregon Health & Science University
Portland, Oregon, United States
Ut Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
the University of Vermont Inc.
Burlington, Vermont, United States
University of Virginia Health System
Charlottesville, Virginia, United States
Childrens Hospital of Milwaukee
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

GlutathionePlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Jun 2017
Primary completion: 12 Dec 2018
Completion: 12 Dec 2018
Last update posted: 9 Jan 2020
Registered enrollment: 60
Registry id: NCT03020719

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.